Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 225,649,472 papers from all fields of science
Search
Sign In
Create Free Account
1-hydroxyphenazine
Known as:
1-Phenazinol
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
1 relation
Broader (1)
Phenazines
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2000
2000
CGS 21680, dibutyryl cyclic AMP and rolipram attenuate the pro-inflammatory interactions of the Pseudomonas aeruginosa -derived pigment, 1-hydroxyphenazine, with human neutrophils.
G. Ramafi
,
R. Anderson
,
+4 authors
P. Cole
Pulmonary Pharmacology & Therapeutics
2000
Corpus ID: 11717689
The effects of the intracellular adenosine 3':5' cyclic monophosphate (cAMP)-elevating agents, CGS 21680 (0.01- 1 microM) and…
Expand
1999
1999
Exposure ofN-Formyl-l-Methionyl-l-Leucyl-l-Phenylalanine-Activated Human Neutrophils to the Pseudomonas aeruginosa-Derived Pigment 1-Hydroxyphenazine Is Associated with Impaired Calcium Efflux and…
G. Ramafi
,
R. Anderson
,
+4 authors
P. Cole
Infection and Immunity
1999
Corpus ID: 26056336
ABSTRACT The effects of pathologically relevant concentrations (0.38 to 12.5 μM) of the proinflammatory, Pseudomonas aeruginosa…
Expand
1996
1996
The effect of bacterial toxins on levels of intracellular adenosine nucleotides and human ciliary beat frequency.
K. Kanthakumar
,
G. Taylor
,
+4 authors
R. Wilson
Pulmonary Pharmacology
1996
Corpus ID: 22761436
Toxins that slow ciliary beat are virulence determinants of bacteria that infect or invade ciliated epithelial surfaces. We have…
Expand
1994
1994
Extracellular metabolites of Pseudomonas aeruginosa produce bronchoconstriction by different mechanisms.
R. Forteza
,
I. Lauredo
,
R. Burch
,
W. Abraham
American Journal of Respiratory and Critical Care…
1994
Corpus ID: 43403672
Bacterial supernatants (BS) obtained from broth cultures of Pseudomonas aeruginosa cause bronchoconstriction in sheep, suggesting…
Expand
1992
1992
Enhanced release of elastase and oxidative inactivation of alpha-1-protease inhibitor by stimulated human neutrophils exposed to Pseudomonas aeruginosa pigment 1-hydroxyphenazine.
G. Ras
,
A. Theron
,
+4 authors
C. A. van der Merwe
Journal of Infectious Diseases
1992
Corpus ID: 26918329
The in vitro effects of the Pseudomonas aeruginosa-derived phenazine pigments pyocyanin and 1-hydroxyphenazine (1-hp) on…
Expand
1992
1992
Impairment of airway mucociliary transport by Pseudomonas aeruginosa products. Role of oxygen radicals.
Z. V. Seybold
,
W. Abraham
,
H. Gazeroglu
,
A. Wanner
American Review of Respiratory Disease
1992
Corpus ID: 24811772
We previously showed that the supernatant of a Pseudomonas aeruginosa (PA) culture and its constituents pyocyanin and 1…
Expand
1992
1992
Clindamycin, erythromycin, and roxithromycin inhibit the proinflammatory interactions of Pseudomonas aeruginosa pigments with human neutrophils in vitro
G. Ras
,
R. Anderson
,
+7 authors
P. Cole
Antimicrobial Agents and Chemotherapy
1992
Corpus ID: 26519648
The Pseudomonas aeruginosa-derived phenazine pigments pyocyanin and 1-hydroxyphenazine (1-hp) prime human neutrophils for…
Expand
1991
1991
Effect of Pseudomonas aeruginosa-derived pyocyanin and 1-hydroxyphenazine on pulmonary mucociliary clearance monitored scintigraphically in the baboon model.
I. Dormehl
,
G. Ras
,
G. Taylor
,
N. Hugo
International Journal of Radiation Applications…
1991
Corpus ID: 25911712
1956
1956
The Practical Synthesis of 1-Phenazinol
D. L. Vivian
Nature
1956
Corpus ID: 4152077
CONSIDERABLE interest has been aroused in 1-phenazinol because of its relatively high antibiotic activity, as brought out in…
Expand
1953
1953
Identification of a copper complex-forming fraction of pyocyanine.
W. Moos
,
J. Rowen
Archives of Biochemistry and Biophysics
1953
Corpus ID: 6069108
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE